
Mankind Pharma Q2 FY27 Results: Consolidated Net Profit ₹716 Crore on Total Income of ₹4,433 Crore
Mankind Pharma (NSE: MANKIND) reported consolidated total income of ₹4,432.71 crore and net profit of ₹716.12 crore for the quarter ended 30 Sep 2026, it said in a filing on 26 Oct 2026. Standalone total income was ₹3,204.05 crore and standalone net profit ₹581.95 crore for the same quarter.
- Earnings
- Pharmaceuticals











